Search - tctmd.com

Displaying 41 - 60 of 299

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2024

Shelley Wood

July 31, 2024

News Daily News

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

Yael L. Maxwell

July 22, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2024

Shelley Wood

July 02, 2024

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

News Daily News

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Caitlin E. Cox

June 21, 2024

News Conference News NY Valves 2024

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Todd Neale

June 14, 2024

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

Presentation NY Valves 2024

How to Define and Manage Subclinical Leaflet Thrombosis

Presenter: Hasan Jilaihawi

June 07, 2024

Presentation NY Valves 2024

Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement

Presenter: Neil P. Fam

June 07, 2024

Presentation NY Valves 2024

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mark Zorman

June 06, 2024

Presentation NY Valves 2024

Thromboaspiration of a Left-Sided Bioprosthetic Valve Thrombosis by a Mini-Invasive Access: A Novel Procedure to Alleviate the Risks of Thrombolysis, Angiovac and Redo-Surgery

Presenter: Ziyad Gunga

June 06, 2024

Presentation NY Valves 2024

Subclinical Leaflet Thrombosis : Identification, Incidence and Importance

Presenter: Raj Makkar

June 06, 2024

News Conference News EuroPCR 2024

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

Caitlin E. Cox

May 24, 2024

News Conference News EuroPCR 2024

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Michael O'Riordan

May 16, 2024

News Conference News EuroPCR 2024

Debate Continues on TAVI Choice for Women With Small Annuli

Yael L. Maxwell

May 14, 2024

News Conference News ACC 2024

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

L.A. McKeown

April 07, 2024

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

News Daily News

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

L.A. McKeown

February 02, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Advertisement

TCTMD’s Top 10 Most Popular Stories for July 2024

Evolut TAVI Shows Promise in Low-risk Bicuspid Patients at 3 Years

TCTMD’s Top 10 Most Popular Stories for June 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Knowns and Unknowns in Subclinical Aortic Valve Thrombosis

Bioprosthetic Valve Dysfunction Tied to Worse Outcomes After AVR

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

How to Define and Manage Subclinical Leaflet Thrombosis

Walking the Tightrope: Bleeding vs Thrombosis Risk Following Transcatheter Tricuspid Valve Replacement

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Thromboaspiration of a Left-Sided Bioprosthetic Valve Thrombosis by a Mini-Invasive Access: A Novel Procedure to Alleviate the Risks of Thrombolysis, Angiovac and Redo-Surgery

Subclinical Leaflet Thrombosis : Identification, Incidence and Importance

Temporary Pacemaker After TAVI May Preclude Long-term Pacing

TAVI, Surgery Look Similar Long-term Across Risk Spectrum: Meta-analysis

Debate Continues on TAVI Choice for Women With Small Annuli

SMART: Small Aortic Annuli May Fare Best With Self-Expandable Valve

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

FDA Approves First Transcatheter Tricuspid Valve Replacement Device

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content